HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Capital Fund II, LP into HAPPE Spine.
Holland-based Genesis Innovation Group LLC raised $7.2 million of its $10 million goal toward a fund to invest in early stage health care companies, particularly those developing medical devices and orthopedic technologies.
The organizers behind the new cultivate(MD) Capital Fund GP LLC found backers by appealing to their own global professional networks and investors with whom they had previously done business.
Many of the approximately 50 investors in the Holland-based venture capital fund are individuals who invested previously in startups spun out of Genesis Innovation Group LLC, a Holland-based developer of emerging medical device technologies whose partners formed cultivate(MD) last fall.
A Holland-based venture capital firm closed last week on $7.2 million of the $10 million it seeks to raise to invest in health care startups.
Formed last fall by Genesis Innovation Group LLC, a developer of emerging medical device technologies, cultivate(MD) Capital Fund GP LLC netted investments from about 50 individual investors. Many investors are individuals who invested previously in startups spun out of Genesis Innovation Group, said Robert Ball, CEO of Genesis and managing director of cultivate(MD).
Genesis Innovation Group and cultivate (MD) Capital Funds are dedicated to bringing emerging health care innovations to market. HOLLAND, Mich., March 6, 2018 —Genesis Innovation Group, LLC, (Genesis) an emerging developer of medical device technologies, today announced that cultivate(MD) Capital Fund GP, LLC (cultivate(MD)), has closed its first tranche of $7.2M in capital funds ofRead more about cultivate(MD) Capital Funds Announces First Tranche Closing […]
Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million
Wright Medical Group N.V. today announced the acquisition of IMASCAP SAS, a leader in the development of software-based solutions for preoperative planning of shoulder replacement surgery.
$10 Million Fund is dedicated to bringing emerging healthcare innovations to market.
HOLLAND, Mich., November 28, 2017—
Genesis Innovation Group, LLC, an emerging developer of medical device technologies, today announced the formation of cultivate(MD) Capital Fund I, LLC, a venture capital fund focused on investing in early-stage healthcare companies, with special focus on medical device and orthopedic technologies. cultivate(MD) LLC is expected to manage $10M, is limited to private placements, and closed to the public. Genesis anticipates the cultivate(MD) fund to be fully operational and actively seeking companies in which to invest by early 2018.
Holland, MI-based Genesis Innovation Group announced early this month that it has raised $1.1 million in capital to invest in new medical device technologies. Since its 2013 inception, Genesis has raised a total of $2.3 million.
Shoulder Innovations, the Holland, MI-based medical device startup, this week announced a $1.5 million Series A round led by the Michigan Angel Fund, with participation from Start Garden, Invest Michigan, Novus Bioventures, Western Michigan University’s Biosciences Research Commercialization Center, and Genesis Innovation Group.